Maya Faissal Alhomieed, Lara Osama Al Hartany, Marya Aref Alghorab, Arwa Alsharif, Ahlam Kaleemullah, Hanan Ismail Wasaya, Khlood Abdulaziz Alsubaie, Ayah Nabil Al Jehani, Amal Mohamed Kayali, Samera AlBasri
{"title":"妊娠对皮肤病的影响:系统综述。","authors":"Maya Faissal Alhomieed, Lara Osama Al Hartany, Marya Aref Alghorab, Arwa Alsharif, Ahlam Kaleemullah, Hanan Ismail Wasaya, Khlood Abdulaziz Alsubaie, Ayah Nabil Al Jehani, Amal Mohamed Kayali, Samera AlBasri","doi":"10.3390/clinpract15040068","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Pregnancy induces hormonal, immunologic, and vascular changes that profoundly affect dermatologic health. This systematic review aimed to assess the impact of pregnancy on dermatological disorders in terms of disease incidence, severity, maternal-fetal outcomes, and optimal management strategies. <b>Methods</b>: A systematic search was performed in PubMed, MEDLINE, and Web of Science databases, following PRISMA guidelines. Studies evaluating pregnant women with dermatological disorders, pregnancy-related dermatoses, and pre-existing morbidities, were included. The collaboratively extracted data included patient demographics, disease severity, treatment approaches, and pregnancy outcomes. <b>Results</b>: A total of 8490 pregnant cases with dermatologic changes and conditions caused by pregnancy were studied. The dermatological conditions were divided into physiological changes, pregnancy-related exacerbation of pre-existing skin conditions, and pregnancy-specific dermatoses. Intrahepatic cholestasis of pregnancy and pemphigoid gestationis were associated with increased rates of adverse fetal outcomes in patients with specific dermatoses, including increased preterm birth and fetal distress rates. The atopic eruption of pregnancy and polymorphic eruption of pregnancy were highly relevant, but their effect on fetal health was minimal. The efficacy and safety of treatment modalities, including corticosteroids, antihistamines, and ursodeoxycholic acid, were variable. <b>Conclusions</b>: Pregnancy drastically affects dermatological health, but the nature of the impact depends on the condition. Optimal maternal and fetal outcomes rely on early diagnosis and individualized management strategies. More randomized controlled trials are required to develop standardized diagnostic and treatment guidelines to enhance the quality of dermatologic care during pregnancy.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 4","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12026094/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Effect of Pregnancy on Dermatological Disorders: A Systematic Review.\",\"authors\":\"Maya Faissal Alhomieed, Lara Osama Al Hartany, Marya Aref Alghorab, Arwa Alsharif, Ahlam Kaleemullah, Hanan Ismail Wasaya, Khlood Abdulaziz Alsubaie, Ayah Nabil Al Jehani, Amal Mohamed Kayali, Samera AlBasri\",\"doi\":\"10.3390/clinpract15040068\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background</b>: Pregnancy induces hormonal, immunologic, and vascular changes that profoundly affect dermatologic health. This systematic review aimed to assess the impact of pregnancy on dermatological disorders in terms of disease incidence, severity, maternal-fetal outcomes, and optimal management strategies. <b>Methods</b>: A systematic search was performed in PubMed, MEDLINE, and Web of Science databases, following PRISMA guidelines. Studies evaluating pregnant women with dermatological disorders, pregnancy-related dermatoses, and pre-existing morbidities, were included. The collaboratively extracted data included patient demographics, disease severity, treatment approaches, and pregnancy outcomes. <b>Results</b>: A total of 8490 pregnant cases with dermatologic changes and conditions caused by pregnancy were studied. The dermatological conditions were divided into physiological changes, pregnancy-related exacerbation of pre-existing skin conditions, and pregnancy-specific dermatoses. Intrahepatic cholestasis of pregnancy and pemphigoid gestationis were associated with increased rates of adverse fetal outcomes in patients with specific dermatoses, including increased preterm birth and fetal distress rates. The atopic eruption of pregnancy and polymorphic eruption of pregnancy were highly relevant, but their effect on fetal health was minimal. The efficacy and safety of treatment modalities, including corticosteroids, antihistamines, and ursodeoxycholic acid, were variable. <b>Conclusions</b>: Pregnancy drastically affects dermatological health, but the nature of the impact depends on the condition. Optimal maternal and fetal outcomes rely on early diagnosis and individualized management strategies. More randomized controlled trials are required to develop standardized diagnostic and treatment guidelines to enhance the quality of dermatologic care during pregnancy.</p>\",\"PeriodicalId\":45306,\"journal\":{\"name\":\"Clinics and Practice\",\"volume\":\"15 4\",\"pages\":\"\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12026094/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/clinpract15040068\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/clinpract15040068","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:怀孕引起激素、免疫和血管的改变,深刻影响皮肤健康。本系统综述旨在评估妊娠对皮肤病发病率、严重程度、母胎结局和最佳管理策略的影响。方法:系统检索PubMed、MEDLINE和Web of Science数据库,遵循PRISMA指南。研究评估了患有皮肤病、妊娠相关皮肤病和既往疾病的孕妇。协作提取的数据包括患者人口统计、疾病严重程度、治疗方法和妊娠结局。结果:共对8490例妊娠期皮肤病变及妊娠引起的疾病进行了研究。皮肤病分为生理性改变、妊娠相关的既往皮肤病加重和妊娠特异性皮肤病。妊娠肝内胆汁淤积和类天疱疮妊娠与特定皮肤病患者不良胎儿结局发生率增加相关,包括早产和胎儿窘迫发生率增加。妊娠特应性爆疹和多形性爆疹高度相关,但对胎儿健康的影响很小。包括皮质类固醇、抗组胺药和熊去氧胆酸在内的治疗方式的有效性和安全性是可变的。结论:妊娠严重影响皮肤健康,但影响的性质取决于条件。最佳的母婴结局依赖于早期诊断和个性化的管理策略。需要更多的随机对照试验来制定标准化的诊断和治疗指南,以提高妊娠期间皮肤科护理的质量。
The Effect of Pregnancy on Dermatological Disorders: A Systematic Review.
Background: Pregnancy induces hormonal, immunologic, and vascular changes that profoundly affect dermatologic health. This systematic review aimed to assess the impact of pregnancy on dermatological disorders in terms of disease incidence, severity, maternal-fetal outcomes, and optimal management strategies. Methods: A systematic search was performed in PubMed, MEDLINE, and Web of Science databases, following PRISMA guidelines. Studies evaluating pregnant women with dermatological disorders, pregnancy-related dermatoses, and pre-existing morbidities, were included. The collaboratively extracted data included patient demographics, disease severity, treatment approaches, and pregnancy outcomes. Results: A total of 8490 pregnant cases with dermatologic changes and conditions caused by pregnancy were studied. The dermatological conditions were divided into physiological changes, pregnancy-related exacerbation of pre-existing skin conditions, and pregnancy-specific dermatoses. Intrahepatic cholestasis of pregnancy and pemphigoid gestationis were associated with increased rates of adverse fetal outcomes in patients with specific dermatoses, including increased preterm birth and fetal distress rates. The atopic eruption of pregnancy and polymorphic eruption of pregnancy were highly relevant, but their effect on fetal health was minimal. The efficacy and safety of treatment modalities, including corticosteroids, antihistamines, and ursodeoxycholic acid, were variable. Conclusions: Pregnancy drastically affects dermatological health, but the nature of the impact depends on the condition. Optimal maternal and fetal outcomes rely on early diagnosis and individualized management strategies. More randomized controlled trials are required to develop standardized diagnostic and treatment guidelines to enhance the quality of dermatologic care during pregnancy.